Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06492603

Examination of Biomechanical Characteristics of Linea Alba in Diastasis Recti Patients

Examination of Linea Alba Biomechanical and Viscoelastic Characteristics in Patients Diagnosed With Diastasis Recti Using Ultrasound

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
South Valley University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Diastasis recti is an increased distance between the rectus abdominis muscles at the midline caused by weakness in the anterior abdominal wall.

Detailed description

Most healthcare providers agree that in diastasis rectus abdominis there is a weakness, thinning, and widening of the linea alba and weakness of the associated abdominal musculature. Ultrasonography is regarded as the most accurate method for measuring the IRD and its results are consistent with the data derived from palpation, calipers, and intraoperative measurements. The MyotonPRO Device is used for the non-invasive measurement of Device is for the non-invasive measurement of biomechanical and viscoelastic properties of superficial soft biological tissues. Skeletal muscles or tendons can be measured at different regions, at full rest or in contraction. This study aims to assess the biomechanical and viscoelastic properties of the Linea Alba in patients who are diagnosed with diastasis rectus abdominis by ultrasonography.

Conditions

Interventions

TypeNameDescription
DEVICEUltrasonographyUltrasound is an assessment device that uses high-energy sound waves to look at either superficial tissues like linea alba and/or organs inside the body. The sound waves make echoes that form pictures of the tissues and organs on a computer screen (sonogram).
DEVICEThe MyotonPRO DeviceThe MyotonPro is a portable device for measuring biomechanical and viscoelastic properties in superficial soft tissues

Timeline

Start date
2025-07-20
Primary completion
2025-11-20
Completion
2025-12-30
First posted
2024-07-09
Last updated
2025-07-03

Source: ClinicalTrials.gov record NCT06492603. Inclusion in this directory is not an endorsement.